DNTRIPLED Medical Services - Moderne Apherese/Modern Apheresis/Nowoczesna Afereza is a private medical center located in Warsaw, Poland. We are the first private clinic in Poland to offer advanced therapeutic apheresis, including Double-Filtration Plasmapheresis (DFPP), LDL apheresis, and hemoperfusion. Procedures are carried out in accordance with recognized American and German apheresis guidelines, ensuring the highest standards of medical care. Our clinic utilizes state-of-the-art apheresis technology from Medica S.p.A. (Italy) together with sterile, single-use treatment sets. Each procedure is supervised by a doctor.
Therapeutic apheresis is a modern blood purification procedure in which disease-causing substances are targetedly removed from the blood using special filters or adsorption cartridges. The safety and effectiveness of apheresis are scientifically proven, recognized by medical professional societies worldwide, and described in apheresis standards for many diseases (see full list at ):
- Autoimmune diseases
- Chronic Fatigue Syndrome
- Long-COVID
- Hyperlipidemia
- Severe Alcohol Intoxication
- Pancreatitis, Hepatitis, Nephritis
- Vasculitis, Atherosclerosis, Myocarditis
- Dermatitis, Eczema, Psoriasis
- Lupus, Rheumatoid Arthritis
- Alzheimer’s Disease
- Myasthenia Gravis
- Demyelinating Diseases
- Allergies
- Multiple Sclerosis
1. Double Filtration Plasmapheresis (DFPP)
Double Filtration Plasmapheresis (DFPP) is a selective extracorporeal plasma filtration technique involving two sequential filtration steps. In the first step, blood passes through a plasma filter that separates plasma from cellular components such as red blood cells. The cellular components are returned to the patient’s circulation.
In the second step, the plasma passes through a second filtration cartridge (fractionator) containing membranes with selected pore sizes. Depending on the fractionator used, substances that may be partially removed include pathogenic immune complexes, certain immunoglobulins, autoantibodies, lipoproteins, inflammatory mediators, heavy metals, and selected toxins. The filtered plasma is then returned to the patient.
Depending on the underlying disease, the reduction of these substances may be associated with:
selective blood purification through removal of autoantibodies, cytokines, toxins, and pathogenic immune complexes
reduction of symptoms in autoimmune diseases
anti-inflammatory effects that may reduce immune system burden
support of natural repair mechanisms and cellular function
improvement in physical and mental performance
potential anti-aging effects at the cellular level
Clinical outcomes depend on the underlying medical condition and cannot be guaranteed. The extent and duration of these effects may vary.
2. LDL Apheresis (DFPP method)
LDL apheresis is a therapeutic apheresis technique designed to selectively remove certain lipoproteins from the bloodstream, particularly low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a).
During the procedure, plasma is separated from the cellular components and passed through adsorption columns or filtration systems designed to selectively bind and remove lipoproteins.
LDL apheresis may contribute to:
- lowering the concentration of atherogenic lipoproteins in the blood
- reducing the risk of acute pancreatitis in patients with severe hypertriglyceridemia
- reducing inflammatory processes in blood vessels and stabilizing atherosclerotic plaques
- slowing the progression of atherosclerosis
- decreasing the risk of cardiovascular complications such as myocardial infarction, stroke, and other cardiovascular events
Clinical outcomes depend on the underlying medical condition and cannot be guaranteed. The extent and duration of these effects may vary.
